AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,658,398 | -15.6% | 107,410 | -3.4% | 0.00% | -33.3% |
| Q2 2023 | $3,148,419 | +25.7% | 111,173 | +2.0% | 0.01% | +50.0% |
| Q1 2023 | $2,504,258 | -19.7% | 109,023 | -1.8% | 0.00% | -33.3% |
| Q4 2022 | $3,117,835 | -0.2% | 111,034 | +0.6% | 0.01% | 0.0% |
| Q3 2022 | $3,123,000 | +126.8% | 110,420 | +77.8% | 0.01% | +500.0% |
| Q2 2022 | $1,377,000 | -14.9% | 62,105 | +11.7% | 0.00% | 0.0% |
| Q1 2022 | $1,619,000 | -2.8% | 55,620 | +10.1% | 0.00% | 0.0% |
| Q4 2021 | $1,666,000 | -27.2% | 50,500 | +1.8% | 0.00% | -50.0% |
| Q3 2021 | $2,290,000 | -16.3% | 49,630 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,735,000 | +8.9% | 49,630 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $2,512,000 | -10.2% | 48,640 | -24.6% | 0.00% | -33.3% |
| Q4 2020 | $2,797,000 | -5.2% | 64,535 | -23.4% | 0.00% | 0.0% |
| Q3 2020 | $2,950,000 | -42.1% | 84,280 | -11.6% | 0.00% | -50.0% |
| Q2 2020 | $5,099,000 | +52.1% | 95,332 | +0.9% | 0.01% | +50.0% |
| Q1 2020 | $3,353,000 | +11.3% | 94,525 | +49.8% | 0.00% | +33.3% |
| Q4 2019 | $3,013,000 | +152.1% | 63,088 | +74.6% | 0.00% | +200.0% |
| Q3 2019 | $1,195,000 | -53.8% | 36,134 | -30.4% | 0.00% | -50.0% |
| Q2 2019 | $2,588,000 | -30.7% | 51,892 | -6.2% | 0.00% | -50.0% |
| Q1 2019 | $3,732,000 | +141.1% | 55,338 | +64.9% | 0.00% | +100.0% |
| Q4 2018 | $1,548,000 | -78.5% | 33,562 | -64.0% | 0.00% | -71.4% |
| Q3 2018 | $7,192,000 | +88.5% | 93,260 | +105.9% | 0.01% | +75.0% |
| Q2 2018 | $3,815,000 | +284.6% | 45,300 | +273.3% | 0.00% | +300.0% |
| Q1 2018 | $992,000 | +42.9% | 12,135 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $694,000 | -14.3% | 12,135 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $810,000 | +27.2% | 12,135 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $637,000 | -10.9% | 12,135 | -1.3% | 0.00% | 0.0% |
| Q1 2017 | $715,000 | +54.8% | 12,300 | +11.1% | 0.00% | – |
| Q4 2016 | $462,000 | -19.5% | 11,074 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $574,000 | +17.6% | 11,074 | -5.1% | 0.00% | 0.0% |
| Q2 2016 | $488,000 | +3.2% | 11,669 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $473,000 | -87.0% | 11,669 | -77.3% | 0.00% | -75.0% |
| Q3 2015 | $3,635,000 | +38.3% | 51,500 | +117.7% | 0.00% | +33.3% |
| Q2 2015 | $2,629,000 | – | 23,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |